Human Fc alpha receptor I (FcαRI, CD89) His+Avi (Biotinylated) for antibody Fc&Fc
Receptor binding affinity assay (Competitive ELISA immunoassay, SRP assay or BLI assay)
Cat No.: GMP-BioFcR-ag-039
Human Fc alpha receptor I (FcαRI, CD89) His+Avi (Biotinylated) is used to measure the affinity of antibodies for it.
The Fc receptor binding assay (Competitive ELISA immunoassay, SRP assay or BLI assay) plays a vital role in the development of
therapeutic antibodies.
GeneMedi provides Human Fc alpha receptor I (FcαRI, CD89) His+Avi (Biotinylated)
The receptor has been classified based on its affinity for IgG1, IgG3, IgG4. The Fc receptor is expressed on many immune cells and binds to the specific immunoglobulin, then modulating the immune response.
Order information
GeneMedi provides two kinds of Human Fc alpha receptor I (FcαRI, CD89)(GMP-BioFcR-ag-039), GMP-BioFcR-ag-039-1 is with the tag His and Avi, GMP-BioFcR-ag-039-2 is Biotinylated and also with the tag His and Avi.
Catalog No. | Description | Price (In USD) |
Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-BioFcR-ag-039-1 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi Size:1mg | 5990 | ||
GMP-BioFcR-ag-039-1 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi Size:10mg | 38790 | ||
GMP-BioFcR-ag-039-1 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi Size:100mg | 258000 | ||
GMP-BioFcR-ag-039-2 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi, Biotinylated Size:1mg | 6990 | ||
GMP-BioFcR-ag-039-2 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi, Biotinylated Size:10mg | 43790 | ||
GMP-BioFcR-ag-039-2 | Human Fc alpha receptor I (FcαRI, CD89) His+Avi, Biotinylated Size:100mg | 293000 | ||
GMP-BioFcR-ag-039 | Size≥100mg | Inquiry | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
Products Name | GMP-BioFcR-ag-039-1: Human Fc alpha receptor I (FcαRI, CD89) His+Avi GMP-BioFcR-ag-039-2: Human Fc alpha receptor I (FcαRI, CD89) His+Avi, Biotinylated |
Products Description | Human Fc alpha receptor I (FcαRI, CD89) His+Avi (Biotinylated) is used to measure the affinity of antibodies for it. The Fc receptor binding assay (Competitive ELISA immunoassay, SRP assay or BLI assay) plays a vital role in the development of therapeutic antibodies. GeneMedi provides Human Fc alpha receptor I (FcαRI, CD89) His+Avi (Biotinylated). The receptor has been classified based on its affinity for IgA . The Fc receptor is expressed on many immune cells and binds to the specific immunoglobulin, then modulating the immune response. |
Isotype | Fc alpha receptor I (FcαRI, CD89) |
Receptor name | Fc alpha receptor I (FcαRI, CD89) |
Species | Human |
Principal antibody ligand | IgA |
Major role | Activation |
Effect following binding to antibody | ADCC, ADCP |
WT/Mutation | WT |
Mutant variants functions vs WT | N/A |
Fc Modifications or Mutations (Reduced effector function) |
|
Fc Modifications or Mutations (Enhanced effector function) |
IgG1/IgA2 (ADCC), IgGA (ADCC, ADCP) |
Application | Antibody Fc&Fc Receptor binding affinity assay (Competitive ELISA immunoassay, SRP assay or BLI assay) |
Formulation | Supplied as a 0.2 μM filtered solution of PBS, PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |